Dexibuprofen

DB09213ApprovedWithdrawnSmall molecule

Dexibuprofen is a pharmacologically active enantiomer of racemic ibuprofen (NSAID) used to treat pain and inflammation. It is a pharmacologically effective enantiomer of racemic ibuprofen that differs in physicochemical properties.

Chemical structure of Dexibuprofen
Mechanism
Curator reviewed · 1 reference
Primary indication
For more information, refer to ibuprofen.Curator reviewed · 6 structured indications
Formula / weight
C13H18O2 · 206.2808 g/mol (avg)
Also known as
d-ibuproten

Resolves to

Structure
InChIKeyHEFNNWSXXWATRW-JTQLQIEISA-NSMILESCC(C)CC1=CC=C(C=C1)[C@H](C)C(O)=O

What you can answer from here — as of June 15, 2026

13Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
8TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,611Drug interactionsStructured to mechanism, not free text
Sign in
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
12ContraindicationsEach with its own population and attribute set
Sign in
104Marketed productsAcross 4 countries and 14 labellers
Sign in
1ATC codeIncluding every combination product, plus 21 drug categories
Sign in
54+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Dexibuprofen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account